Correlation Between Crescita Therapeutics and BC Bud

Can any of the company-specific risk be diversified away by investing in both Crescita Therapeutics and BC Bud at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crescita Therapeutics and BC Bud into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Crescita Therapeutics and The BC Bud, you can compare the effects of market volatilities on Crescita Therapeutics and BC Bud and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crescita Therapeutics with a short position of BC Bud. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crescita Therapeutics and BC Bud.

Diversification Opportunities for Crescita Therapeutics and BC Bud

0.3

Correlation Coefficient

Crescita Therapeutics  BC Bud

Weak diversification

The 3 months correlation between Crescita and BCBCF is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Crescita Therapeutics and The BC Bud in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BC Bud and Crescita Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crescita Therapeutics are associated (or correlated) with BC Bud. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BC Bud has no effect on the direction of Crescita Therapeutics i.e., Crescita Therapeutics and BC Bud go up and down completely randomly.

Pair Corralation between Crescita Therapeutics and BC Bud

Assuming the 90 days horizon Crescita Therapeutics is expected to generate 2.12 times more return on investment than BC Bud. However, Crescita Therapeutics is 2.12 times more volatile than The BC Bud. It trades about 0.12 of its potential returns per unit of risk. The BC Bud is currently generating about 0.15 per unit of risk. If you would invest  2.10  in Crescita Therapeutics on September 3, 2024 and sell it today you would earn a total of  42.90  from holding Crescita Therapeutics or generate 2042.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Crescita Therapeutics  vs.  The BC Bud

Crescita Therapeutics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Crescita Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Crescita Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

BC Bud

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in The BC Bud are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, BC Bud reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Crescita Therapeutics and BC Bud

The main advantage of trading using opposite Crescita Therapeutics and BC Bud positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crescita Therapeutics position performs unexpectedly, BC Bud can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BC Bud will offset losses from the drop in BC Bud's long position.

The idea behind Crescita Therapeutics and The BC Bud pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.